Saffron
Natural health product licensed in Canada
- Other names
- Affron Saffron, Saffron Capsules
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80149978
- Status
- Active licence
- Licence date
- 23 July 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crocus sativus Source : Crocus sativus - Stigmate Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 90 mg Potency : 3.48 % Crocin | 30 mg | Not calculated |
| Crocus sativus Source : Crocus sativus - Stigmate Potency : 0.03 % 2,6,6-Trimethylcyclohexa-1,3-diene-1-carbaldehyde | Not specified | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Silice, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Help to relieve symptoms of premenstrual syndrome Helps to support/maintain healthy mood balance. Clinically proven to help support/maintain healthy mood balance. Helps to support mood balance after awakening. Clinically shown to help support positive effects on symptoms of perceived stress such as fatigue, weariness, and irritability. Clinically shown to help reduce the symptoms of perceived stress, such as fatigue, weariness, and irritability. Saffron is clinically shown to help relieve restlessness and/or nervousness (calmative). Helps to improve restorative sleep in individuals experiencing sleeplessness. Helps improve sleep quality in individuals experiencing sleeplessness. Helps improves sleep quality. Clinically proven to help improve sleep quality. Clinically proven to help improve sleep quality in 4 weeks. Clinically proven to help improve sleep quality in individuals experiencing sleeplessness. Supports the management of symptoms associated with perimenopause. Clinically shown to help relieve symptoms associated with perimenopause. May help to support healthy mood balance during perimenopause. Clinically shown to help improve restorative sleep in individuals experiencing sleeplessness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80149978
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.